Clinical Trial Update: CX717 in the Treatment of Adult ADHD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CX717 in adults with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CX717

Snippet

Sponsor: RespireRx | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED